17.07.2015 • News

Leaving the Patent Cliff Behind

The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020 while worldwide prescription drug sales are expected to reach almost one trillion dollars by 2020. This is the conclusion of the World Preview 2015 report from EvaluatePharma, a specialist in life science sector analysis and consensus forecasts.

The report, which is based on the companies coverage of the world’s leading pharmaceutical and biotech companies and on consensus forecasts says that key prescription drug sales jumped 4.9% in 2014, driven by an 8.9% surge in USA sales. In the same year Europe returned to growth at 2.4% while Japan slumped 2.6% in yen.

CHEManager International will publish a comprehensive analysis of the results presented in the World Preview 2015 report in one of its upcoming issues. The report itself is available here.

pharmaceutical industry

Interview

Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.